A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Vericel Corp stock. As of the latest transaction made, Renaissance Technologies LLC holds 80,300 shares of VCEL stock, worth $4.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
80,300
Previous 99,800 19.54%
Holding current value
$4.6 Million
Previous $4.58 Million 25.91%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$42.25 - $53.56 $823,875 - $1.04 Million
-19,500 Reduced 19.54%
80,300 $3.39 Million
Q2 2024

Aug 09, 2024

SELL
$41.71 - $52.9 $1.45 Million - $1.84 Million
-34,692 Reduced 25.79%
99,800 $4.58 Million
Q1 2024

May 13, 2024

BUY
$32.52 - $52.33 $1.83 Million - $2.95 Million
56,300 Added 72.0%
134,492 $7 Million
Q4 2023

Feb 13, 2024

BUY
$30.85 - $37.09 $838,873 - $1.01 Million
27,192 Added 53.32%
78,192 $2.78 Million
Q3 2023

Nov 14, 2023

BUY
$31.69 - $39.25 $1.62 Million - $2 Million
51,000 New
51,000 $1.71 Million
Q2 2021

Aug 13, 2021

SELL
$47.2 - $67.81 $429,142 - $616,528
-9,092 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$30.93 - $59.48 $290,742 - $559,112
-9,400 Reduced 50.83%
9,092 $505,000
Q4 2020

Feb 10, 2021

BUY
$18.53 - $31.5 $342,656 - $582,498
18,492 New
18,492 $571,000
Q3 2020

Nov 13, 2020

SELL
$14.68 - $19.12 $769,114 - $1 Million
-52,392 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$8.5 - $15.82 $287,886 - $535,807
-33,869 Reduced 39.26%
52,392 $724,000
Q1 2020

May 14, 2020

BUY
$7.25 - $19.22 $625,392 - $1.66 Million
86,261 New
86,261 $791,000
Q2 2019

Aug 12, 2019

SELL
$15.01 - $18.89 $5.42 Million - $6.82 Million
-361,092 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$16.23 - $20.29 $1.02 Million - $1.28 Million
63,100 Added 21.18%
361,092 $6.32 Million
Q4 2018

Feb 13, 2019

BUY
$10.77 - $18.44 $3.21 Million - $5.49 Million
297,992 New
297,992 $5.19 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.7B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.